Moomoo AI 已提取核心信息
On February 9, 2024, Canopy Growth Corporation, a leading North American cannabis and consumer packaged goods company, reported its financial results for the third quarter of the fiscal year 2024, which ended on December 31, 2023. The company announced a 9% year-over-year increase in Canada adult-use cannabis business-to-business net revenue and an 11% increase in Canada medical cannabis net revenue. Canopy Growth achieved a consolidated gross margin of 36% for the quarter, marking a significant improvement from the previous year's negative margins. The company also reported a 54% sequential increase in net revenue for Storz & Bickel, driven by strong sales of the new VENTY portable vaporizer. Despite a 7% year-over-year decline in consolidated net revenue, which totaled $79 million, the company saw an...Show More
On February 9, 2024, Canopy Growth Corporation, a leading North American cannabis and consumer packaged goods company, reported its financial results for the third quarter of the fiscal year 2024, which ended on December 31, 2023. The company announced a 9% year-over-year increase in Canada adult-use cannabis business-to-business net revenue and an 11% increase in Canada medical cannabis net revenue. Canopy Growth achieved a consolidated gross margin of 36% for the quarter, marking a significant improvement from the previous year's negative margins. The company also reported a 54% sequential increase in net revenue for Storz & Bickel, driven by strong sales of the new VENTY portable vaporizer. Despite a 7% year-over-year decline in consolidated net revenue, which totaled $79 million, the company saw an 81% increase in Rest-of-World cannabis revenue, attributed to growth in Australia and Europe. Canopy Growth's free cash flow from continuing operations improved by 57% year-over-year, and the company reduced its overall debt by $69 million during the quarter. Management reaffirmed its expectation to achieve positive Adjusted EBITDA in each business unit by the end of FY2024. Additionally, Canopy Growth is moving forward with its Canopy USA strategy, with a special shareholder meeting scheduled for April 12, 2024, to discuss the creation of a new class of exchangeable shares, which would provide investors with exposure to the U.S. cannabis market.
2024年2月9日，北美领先的大麻和消费品包装公司Canopy Growth Corporation公布了截至2023年12月31日的2024财年第三季度的财务业绩。该公司宣布，加拿大成人用大麻企业对企业净收入同比增长9％，加拿大医用大麻净收入增长11％。Canopy Growth在本季度实现了36％的合并毛利率，与去年的负利润率相比有了显著改善。该公司还报告称，受新款VENTY便携式蒸发器的强劲销售推动，Storz & Bickel的净收入连续增长54％。尽管合并净收入同比下降7％，总额为7,900万美元，但由于澳大利亚和欧洲的增长，该公司的世界其他地区大麻收入增长了81％。Canopy G...展开全部
2024年2月9日，北美领先的大麻和消费品包装公司Canopy Growth Corporation公布了截至2023年12月31日的2024财年第三季度的财务业绩。该公司宣布，加拿大成人用大麻企业对企业净收入同比增长9％，加拿大医用大麻净收入增长11％。Canopy Growth在本季度实现了36％的合并毛利率，与去年的负利润率相比有了显著改善。该公司还报告称，受新款VENTY便携式蒸发器的强劲销售推动，Storz & Bickel的净收入连续增长54％。尽管合并净收入同比下降7％，总额为7,900万美元，但由于澳大利亚和欧洲的增长，该公司的世界其他地区大麻收入增长了81％。Canopy Growth来自持续经营业务的自由现金流同比增长了57％，该公司在本季度的总债务减少了6900万美元。管理层重申，预计在 FY2024 结束之前，每个业务部门的调整后息税折旧摊销前利润将实现正数。此外，Canopy Growth正在推进其Canopy USA战略，计划于2024年4月12日举行特别股东会议，讨论创建新的可交换股票类别的问题，这将为投资者提供进入美国大麻市场的机会。
有用
没用